Patents by Inventor Alexander Rueck

Alexander Rueck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER
    Publication number: 20110257021
    Abstract: The present invention refers to the use of the Mst protein or a nucleotide sequence coding for the Mst protein for the treatment of a thromboembolic disorder and to a method of screening a modulator of the Mst protein or the nucleotide sequence coding for the Mst protein.
    Type: Application
    Filed: April 28, 2011
    Publication date: October 20, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Paola CONCARI, Matthias HERRMANN, Jochen KRUIP, Thomas LEEUW, Alexander RUECK
  • NUCLEIC ACID FLUORESCENT STAINS
    Publication number: 20100041045
    Abstract: The present invention provides fluorescent dye compounds and methods of using the compounds for the staining of nucleic acids including qPCR applications. In particular, the dye compounds comprise heterocyclic molecules with hydroxy alkyl and aromatic substituents, and the dye compounds form highly fluorescent complexes upon nucleic acid binding.
    Type: Application
    Filed: July 14, 2009
    Publication date: February 18, 2010
    Applicant: SIGMA-ALDRICH CO.
    Inventors: Alexander Rueck, Bernhard Schoenenberger, Sergiy Yarmoluk, Vladyslava Kovalska, Mykhaylo Losytskyy, Yurii Slominskii
  • USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER
    Publication number: 20090149375
    Abstract: The present invention refers to the use of the Mst protein or a nucleotide sequence coding for the Mst protein for the treatment of a thromboembolic disorder and to a method of screening a modulator of the Mst protein or the nucleotide sequence coding for the Mst protein.
    Type: Application
    Filed: March 20, 2006
    Publication date: June 11, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Paola Concari, Matthias Herrmann, Jochen Kruip, Thomas Leeuw, Alexander Rueck
  • NUCLEIC ACID FLUORESCENT STAINS
    Publication number: 20090131279
    Abstract: The present invention provides fluorescent dye compounds and methods of using the compounds for the staining of nucleic acids. In particular, the dye compounds comprise heterocyclic molecules with hydroxy alkyl and aromatic substituents, and the dye compounds form highly fluorescent complexes upon nucleic acid binding.
    Type: Application
    Filed: November 15, 2007
    Publication date: May 21, 2009
    Applicant: SIGMA ALDRICH COMPANY
    Inventors: Alexander Rueck, Bernhard Schoenenberger
  • Detection of polyamino acids using trimethincyanine dyes
    Publication number: 20060207881
    Abstract: The present invention is generally directed to a method for detecting polyamino acids. More specifically, the present invention is directed to a method for detecting polyamino acids using trimethincyanine dyes that interact non-covalently with polyamino acids to produce an optically detectable dye/polyamino acid complex.
    Type: Application
    Filed: February 1, 2006
    Publication date: September 21, 2006
    Applicant: Sigma-Aldrich Co.
    Inventors: Vladyslava Kovalska, Dmytro Kryvorotenko, Mykhaylo Losytskyy, Pierre Nording, Alexander Rueck, Bernhard Schoenenberger, Sergiy Yarmoluk, Fabian Wahl
  • Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease
    Publication number: 20050175601
    Abstract: The present invention relates to LIMK-1, a LIMK-1-analogue or LIMK-1 ligand for the binding to GPIIb and/or activation or inhibition of GPIIb/IIIa downstream signaling, for the production of a medicament for the prevention or treatment of a thrombus formation or blood clotting disease, methods of screening a LIMK-1 analogue or a LIMK-1 ligand and a method for producing a medicament for the treatment of a thrombus formation or blood clotting disease.
    Type: Application
    Filed: November 17, 2004
    Publication date: August 11, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Alexander Rueck, Thomas Leeuw, Matthias Herrmann, Gertrud Sibenhorn